Antares Pharma Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
63,081.50
40,031.30
47,910.90
27,714.60
31,555.00
27,892
Total Accounts Receivable
1,034.50
3,510.10
7,952.50
9,073.20
11,878.00
29,418
Inventories
6,461.10
5,859.90
5,724.40
5,327.00
9,275.00
11,350
Other Current Assets
1,706.70
2,322.50
3,274.30
1,376.30
2,323.00
2,648
Total Current Assets
72,283.80
51,723.80
64,862.00
43,491.00
55,031.00
71,308
Net Property, Plant & Equipment
6,952.30
10,828.70
14,793.10
17,867.40
16,158.00
14,895
Total Investments and Advances
6,008.20
-
-
-
-
-
Intangible Assets
2,440.50
3,980.40
3,529.90
3,140.00
2,496.00
1,926
Other Assets
1,247.20
2,239.90
1,377.20
1,827.10
653.00
148
Total Assets
88,931.90
68,772.80
84,562.20
66,325.50
74,338.00
88,277
Accounts Payable
6,378.70
10,071.50
5,187.70
7,885.00
5,957.00
Other Current Liabilities
9,984.30
14,156.10
11,631.90
12,021.90
9,776.00
Total Current Liabilities
16,363.00
24,227.60
16,819.60
19,906.90
15,733.00
Long-Term Debt
-
-
-
-
24,858.00
Other Liabilities
1,855.20
3,349.00
700.00
1,200.00
200.00
Total Liabilities
18,218.20
27,576.60
17,519.60
21,106.90
40,791.00
Common Equity (Total)
70,713.70
41,196.20
67,042.60
45,218.50
33,547.00
Total Shareholders' Equity
70,713.70
41,196.20
67,042.60
45,218.50
33,547.00
Total Equity
70,713.70
41,196.20
67,042.60
45,218.50
33,547.00
Liabilities & Shareholders' Equity
88,931.90
68,772.80
84,562.20
66,325.50
74,338.00
About Antares Pharma
View Profile
